Gene: RNFT2
Official Full Name: ring finger protein, transmembrane 2provided by HGNC
Gene Summary: Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in positive regulation of ERAD pathway. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24510 | RNFT2 Knockout cell line (HeLa) | Human | RNFT2 | 1:3~1:6 | Negative | Online Inquiry |
KO24511 | RNFT2 Knockout cell line (HCT 116) | Human | RNFT2 | 1:2~1:4 | Negative | Online Inquiry |
KO24512 | RNFT2 Knockout cell line (HEK293) | Human | RNFT2 | 1:3~1:6 | Negative | Online Inquiry |
KO24513 | RNFT2 Knockout cell line (A549) | Human | RNFT2 | 1:3~1:4 | Negative | Online Inquiry |
RNFT2 Gene Knockout Cell Lines are specialized cellular models that have been genetically modified to disrupt the expression of the RNFT2 gene. These cell lines are invaluable tools for researchers studying gene function, signal transduction pathways, and the biological roles of RNFT2 in various cellular contexts. By employing techniques such as CRISPR-Cas9 or homologous recombination, these knockout models facilitate the precise genetic alteration needed to elucidate the functional implications of RNFT2 in physiological and pathological processes.
The key function of RNFT2 Gene Knockout Cell Lines lies in their ability to enable researchers to observe phenotypic changes resulting from the loss of RNFT2 function. This understanding can lead to insights into its role in disease mechanisms, including cancer progression, where altered RNFT2 expression is often implicated. Additionally, these models are crucial for drug discovery programs, allowing scientists to assess how the knockout impacts drug efficacy and mechanism of action.
In terms of scientific importance, RNFT2 knockout models serve as foundational tools in both basic and translational research settings. Their utility in studying gene function underpins advancements in gene therapy, regenerative medicine, and personalized medicine approaches. Compared to alternative models, RNFT2 Gene Knockout Cell Lines stand out due to their specificity, robustness, and reproducibility.
Furthermore, the absence of RNFT2 in these cell lines allows for targeted investigations that can reveal potential therapeutic targets, ultimately accelerating the development of novel treatments. For researchers and clinicians seeking to deepen their understanding of RNFT2's implications in health and disease, these knockout cell lines provide a powerful resource to generate impactful data.
Our company specializes in developing high-quality biological products and supports researchers with a commitment to excellence and innovation. With expertise in genetic engineering and cellular biology, we aim to empower the scientific community with reliable tools, like RNFT2 Gene Knockout Cell Lines, that facilitate groundbreaking discoveries and enhance therapeutic strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.